Literature DB >> 36002234

A Rapid Translational Immune Response Program in CD8 Memory T Lymphocytes.

Darin Salloum1, Kamini Singh1,2, Natalie R Davidson3,4,5, Linlin Cao6, David Kuo7, Viraj R Sanghvi1,8, Man Jiang1, Maria Tello Lafoz9, Agnes Viale10, Gunnar Ratsch3,4,5, Hans-Guido Wendel11.   

Abstract

The activation of memory T cells is a very rapid and concerted cellular response that requires coordination between cellular processes in different compartments and on different time scales. In this study, we use ribosome profiling and deep RNA sequencing to define the acute mRNA translation changes in CD8 memory T cells following initial activation events. We find that initial translation enables subsequent events of human and mouse T cell activation and expansion. Briefly, early events in the activation of Ag-experienced CD8 T cells are insensitive to transcriptional blockade with actinomycin D, and instead depend on the translation of pre-existing mRNAs and are blocked by cycloheximide. Ribosome profiling identifies ∼92 mRNAs that are recruited into ribosomes following CD8 T cell stimulation. These mRNAs typically have structured GC and pyrimidine-rich 5' untranslated regions and they encode key regulators of T cell activation and proliferation such as Notch1, Ifngr1, Il2rb, and serine metabolism enzymes Psat1 and Shmt2 (serine hydroxymethyltransferase 2), as well as translation factors eEF1a1 (eukaryotic elongation factor α1) and eEF2 (eukaryotic elongation factor 2). The increased production of receptors of IL-2 and IFN-γ precedes the activation of gene expression and augments cellular signals and T cell activation. Taken together, we identify an early RNA translation program that acts in a feed-forward manner to enable the rapid and dramatic process of CD8 memory T cell expansion and activation.
Copyright © 2022 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 36002234      PMCID: PMC9492650          DOI: 10.4049/jimmunol.2100537

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.426


  55 in total

Review 1.  Network motifs: theory and experimental approaches.

Authors:  Uri Alon
Journal:  Nat Rev Genet       Date:  2007-06       Impact factor: 53.242

2.  Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions.

Authors:  Viveka Mayya; Deborah H Lundgren; Sun-Il Hwang; Karim Rezaul; Linfeng Wu; Jimmy K Eng; Vladimir Rodionov; David K Han
Journal:  Sci Signal       Date:  2009-08-18       Impact factor: 8.192

Review 3.  Perspectives for computer modeling in the study of T cell activation.

Authors:  Jesse Coward; Ronald N Germain; Grégoire Altan-Bonnet
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-05-05       Impact factor: 10.005

4.  Metabolism and autophagy in the immune system: immunometabolism comes of age.

Authors:  Jeffrey C Rathmell
Journal:  Immunol Rev       Date:  2012-09       Impact factor: 12.988

Review 5.  Translational control by 5'-untranslated regions of eukaryotic mRNAs.

Authors:  Alan G Hinnebusch; Ivaylo P Ivanov; Nahum Sonenberg
Journal:  Science       Date:  2016-06-17       Impact factor: 47.728

6.  Genome-wide analysis in vivo of translation with nucleotide resolution using ribosome profiling.

Authors:  Nicholas T Ingolia; Sina Ghaemmaghami; John R S Newman; Jonathan S Weissman
Journal:  Science       Date:  2009-02-12       Impact factor: 47.728

7.  A unifying model for mTORC1-mediated regulation of mRNA translation.

Authors:  Carson C Thoreen; Lynne Chantranupong; Heather R Keys; Tim Wang; Nathanael S Gray; David M Sabatini
Journal:  Nature       Date:  2012-05-02       Impact factor: 49.962

8.  The Translational Machinery of Human CD4+ T Cells Is Poised for Activation and Controls the Switch from Quiescence to Metabolic Remodeling.

Authors:  Sara Ricciardi; Nicola Manfrini; Roberta Alfieri; Piera Calamita; Maria Cristina Crosti; Simone Gallo; Rolf Müller; Massimiliano Pagani; Sergio Abrignani; Stefano Biffo
Journal:  Cell Metab       Date:  2018-12-04       Impact factor: 27.287

9.  c-MYC regulates mRNA translation efficiency and start-site selection in lymphoma.

Authors:  Kamini Singh; Jianan Lin; Yi Zhong; Antonija Burčul; Prathibha Mohan; Man Jiang; Liping Sun; Vladimir Yong-Gonzalez; Agnes Viale; Justin R Cross; Ronald C Hendrickson; Gunnar Rätsch; Zhengqing Ouyang; Hans-Guido Wendel
Journal:  J Exp Med       Date:  2019-05-29       Impact factor: 14.307

10.  The serine hydroxymethyltransferase-2 (SHMT2) initiates lymphoma development through epigenetic tumor suppressor silencing.

Authors:  Sara Parsa; Ana Ortega-Molina; Hsia-Yuan Ying; Man Jiang; Matt Teater; Jiahui Wang; Chunying Zhao; Ed Reznik; Joyce P Pasion; David Kuo; Prathibha Mohan; Shenqiu Wang; Jeannie M Camarillo; Paul M Thomas; Neeraj Jain; Javier Garcia-Bermudez; Byoung-Kyu Cho; Wayne Tam; Neil L Kelleher; Nicholas Socci; Ahmet Dogan; Elisa De Stanchina; Giovanni Ciriello; Michael R Green; Sheng Li; Kivanc Birsoy; Ari M Melnick; Hans-Guido Wendel
Journal:  Nat Cancer       Date:  2020-06-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.